Aclaris Therapeutics Publishes Presentation on ATI-052 Phase 1b Results
Aclaris Therapeutics published a presentation on Phase 1b results for ATI-052 in atopic dermatitis and asthma.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Aclaris Therapeutics published a presentation on Phase 1b results for ATI-052 in atopic dermatitis and asthma.